168 related articles for article (PubMed ID: 3138056)
1. Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo.
Greenblatt DJ; Harmatz JS; Dorsey C; Shader RI
Clin Pharmacol Ther; 1988 Sep; 44(3):326-34. PubMed ID: 3138056
[TBL] [Abstract][Full Text] [Related]
2. Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
Kroboth PD; Folan MM; Lush RM; Chaikin PC; Shukla UA; Barbhaiya R; Salazar DE
J Clin Psychopharmacol; 1995 Oct; 15(5):306-19. PubMed ID: 8830061
[TBL] [Abstract][Full Text] [Related]
3. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam.
Busto UE; Kaplan HL; Wright CE; Gomez-Mancilla B; Zawertailo L; Greenblatt DJ; Sellers EM
J Clin Psychopharmacol; 2000 Dec; 20(6):628-35. PubMed ID: 11106134
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytics and memory: a comparison of lorazepam and alprazolam.
Kumar R; Mac DS; Gabrielli WF; Goodwin DW
J Clin Psychiatry; 1987 Apr; 48(4):158-60. PubMed ID: 3558328
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations and clinical effects after single oral doses of prazepam, clorazepate, and diazepam.
Shader RI; Pary RJ; Harmatz JS; Allison S; Locniskar A; Greenblatt DJ
J Clin Psychiatry; 1984 Oct; 45(10):411-3. PubMed ID: 6148339
[TBL] [Abstract][Full Text] [Related]
6. Cognitive effects of beta-adrenergic antagonists after single doses: pharmacokinetics and pharmacodynamics of propranolol, atenolol, lorazepam, and placebo.
Greenblatt DJ; Scavone JM; Harmatz JS; Engelhardt N; Shader RI
Clin Pharmacol Ther; 1993 May; 53(5):577-84. PubMed ID: 8098277
[TBL] [Abstract][Full Text] [Related]
7. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation.
Pomara N; Tun H; DaSilva D; Hernando R; Deptula D; Greenblatt DJ
Psychopharmacol Bull; 1998; 34(2):139-53. PubMed ID: 9640992
[TBL] [Abstract][Full Text] [Related]
8. The effects of a single oral dose of lorazepam and alprazolam on reaction times in young healthy volunteers.
Crombez G; Kupers R; Adriaensen H
Acta Anaesthesiol Belg; 1991; 42(2):79-84. PubMed ID: 1927238
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC
Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
[TBL] [Abstract][Full Text] [Related]
10. Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder.
Cohn JB; Wilcox CS
Pharmacotherapy; 1984; 4(2):93-8. PubMed ID: 6144090
[TBL] [Abstract][Full Text] [Related]
11. Effects of alprazolam and lorazepam on catecholaminergic and cardiovascular activity during supine rest, mental load and orthostatic challenge.
van den Berg F; Tulen JH; Boomsma F; Noten JB; Moleman P; Pepplinkhuizen L
Psychopharmacology (Berl); 1996 Nov; 128(1):21-30. PubMed ID: 8944402
[TBL] [Abstract][Full Text] [Related]
12. Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects.
Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI
J Clin Pharmacol; 1998 Jan; 38(1):14-21. PubMed ID: 9597554
[TBL] [Abstract][Full Text] [Related]
13. Sedative effects and impaired learning and recall after single oral doses of lorazepam.
Shader RI; Dreyfuss D; Gerrein JR; Harmatz JS; Allison SJ; Greenblatt DJ
Clin Pharmacol Ther; 1986 May; 39(5):526-9. PubMed ID: 3698460
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic analysis of sedative and amnesic effects of lorazepam in healthy volunteers.
Blin O; Simon N; Jouve E; Habib M; Gayraud D; Durand A; Bruguerolle B; Pisano P
Clin Neuropharmacol; 2001; 24(2):71-81. PubMed ID: 11307041
[TBL] [Abstract][Full Text] [Related]
15. Increased sensitivity to alprazolam in females with a paternal history of alcoholism.
Evans SM; Levin FR; Fischman MW
Psychopharmacology (Berl); 2000 Jun; 150(2):150-62. PubMed ID: 10907668
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys.
Friedman H; Redmond DE; Greenblatt DJ
Psychopharmacology (Berl); 1991; 104(1):103-5. PubMed ID: 1881994
[TBL] [Abstract][Full Text] [Related]
17. Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests.
Vermeeren A; Jackson JL; Muntjewerff ND; Quint PJ; Harrison EM; O'Hanlon JF
Psychopharmacology (Berl); 1995 Mar; 118(1):1-9. PubMed ID: 7597114
[TBL] [Abstract][Full Text] [Related]
18. Alprazolam and lorazepam effects on memory acquisition and retrieval processes.
Block RI; Berchou R
Pharmacol Biochem Behav; 1984 Feb; 20(2):233-41. PubMed ID: 6144110
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state.
Scavone JM; Greenblatt DJ; Goddard JE; Friedman H; Harmatz JS; Shader RI
Eur J Clin Pharmacol; 1992; 42(4):439-43. PubMed ID: 1516609
[TBL] [Abstract][Full Text] [Related]
20. Lorazepam vs. alprazolam in the treatment of panic disorder.
Schweizer E; Pohl R; Balon R; Fox I; Rickels K; Yeragani VK
Pharmacopsychiatry; 1990 Mar; 23(2):90-3. PubMed ID: 2187213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
